3.81
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.71
Aprire:
$3.7
Volume 24 ore:
145.20K
Relative Volume:
0.36
Capitalizzazione di mercato:
$228.15M
Reddito:
-
Utile/perdita netta:
$-40.33M
Rapporto P/E:
-2.1285
EPS:
-1.79
Flusso di cassa netto:
$-39.53M
1 W Prestazione:
+0.79%
1M Prestazione:
+46.54%
6M Prestazione:
-10.35%
1 anno Prestazione:
+21.73%
Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile
Nome
Eledon Pharmaceuticals Inc
Settore
Industria
Telefono
949-238-8090
Indirizzo
19800 MACARTHUR BLVD., IRVINE
Confronta ELDN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ELDN
Eledon Pharmaceuticals Inc
|
3.81 | 222.16M | 0 | -40.33M | -39.53M | -1.79 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-06-18 | Ripresa | H.C. Wainwright | Buy |
2025-01-28 | Iniziato | Guggenheim | Buy |
2022-05-13 | Ripresa | Cantor Fitzgerald | Overweight |
2021-03-23 | Iniziato | Cantor Fitzgerald | Overweight |
Eledon Pharmaceuticals Inc Borsa (ELDN) Ultime notizie
What drives Eledon Pharmaceuticals Inc. stock priceExceptional market performance - Autocar Professional
Is Eledon Pharmaceuticals Inc. a good long term investmentUnmatched market gains - Autocar Professional
What analysts say about Eledon Pharmaceuticals Inc. stockRobust financial gains - jammulinksnews.com
How Eledon Pharmaceuticals Inc. stock performs during market volatilityDefensive Stock Picks with Upside - Newser
Eledon Pharmaceuticals Inc. Stock Analysis and ForecastExtraordinary performance - jammulinksnews.com
Midday Stock Roundup: loanDepot Shoots Up 16% - Orange County Business Journal
Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b - GlobeNewswire
Eledon to present updated kidney transplant study data at WTC By Investing.com - Investing.com South Africa
Eledon to present updated kidney transplant study data at WTC - Investing.com
New Phase 1b Data: Tegoprubart Shows Promise in Preventing Kidney Transplant Rejection30 Patient Update - Stock Titan
Why Eledon Pharmaceuticals Inc. stock attracts strong analyst attentionWeekly Double Return List - Newser
What makes Eledon Pharmaceuticals Inc. stock price move sharplyWealth Accumulation Stock List - Newser
Best Momentum Stocks to Buy for July 14th - Yahoo Finance
What is Lifesci Capital’s Estimate for ELDN Q2 Earnings? - Defense World
Cantor Fitzgerald reiterates Overweight rating on Eledon Pharmaceuticals stock By Investing.com - Investing.com Canada
Eledon Pharmaceuticals Rings the Closing Bell - Nasdaq
Extending Transplant Life Through Targeted Innovation - the-scientist.com
Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | SEOVF Stock News - GuruFocus
Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes - The Manila Times
Breakthrough: New Drug Collaboration Shows 5X Better Results in Type 1 Diabetes Cure Trial - Stock Titan
Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) high institutional ownership speaks for itself as stock continues to impress, up 12% over last week - simplywall.st
Eledon Pharmaceuticals, Inc.(NasdaqCM:ELDN) added to Russell Small Cap Comp Growth Index - MarketScreener
Eledon stock rating reiterated as Overweight by Cantor Fitzgerald - Investing.com Canada
Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New Yo - GuruFocus
Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City - Business Upturn
Eledon Pharmaceuticals: A Transplant Breakthrough on the Horizon? - AInvest
What is HC Wainwright’s Estimate for ELDN Q2 Earnings? - Defense World
What is HC Wainwright’s Estimate for ELDN Q1 Earnings? - Defense World
Eledon Pharmaceuticals (NASDAQ:ELDN) Rating Increased to Buy at HC Wainwright - Defense World
ELDN: HC Wainwright & Co. Sets New Price Target for Eledon Pharm - GuruFocus
H.C. Wainwright assumes coverage on Eledon stock with buy rating By Investing.com - Investing.com UK
H.C. Wainwright Reaffirms Buy Rating for Eledon Pharmaceuticals - GuruFocus
Bank of America Corp DE Increases Stock Holdings in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Eledon Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks
Eledon Pharmaceuticals Inc Azioni (ELDN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):